Arnauld Villers

Arnauld Villers

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 309 publications

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Prostate Cancer Mortality in Men not Attending a Population-based Screening Program: The 'Good', the 'Bad', and the 'Ugly' After 20-yr Follow-up in the European Randomised study of Screening for Prostate Cancer.

Journal: European urology open science

Published: June 14, 2026

Long-term Prediction of Metastatic Recurrence in Patients Candidate to Radical Prostatectomy Using MRI and Targeted Biopsy: Insights into Tumor Zonal Origin.

Long-term Prediction of Metastatic Recurrence in Patients Candidate to Radical Prostatectomy Using MRI and Targeted Biopsy: Insights into Tumor Zonal Origin.

Journal: European urology oncology

Published: March 30, 2026

PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers.

PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers.

Journal: European urology oncology

Published: November 26, 2025

European Study of Prostate Cancer Screening - 23-Year Follow-up.

European Study of Prostate Cancer Screening - 23-Year Follow-up.

Journal: The New England journal of medicine

Published: October 29, 2025

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Journal: The New England journal of medicine

Published: October 22, 2025

Re: quantifying Gleason pattern 4: the multifocality blind spot in prognostic models.

Re: quantifying Gleason pattern 4: the multifocality blind spot in prognostic models.

Journal: BJU international

Published: October 19, 2025

Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study).

Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study).

Journal: European urology oncology

Published: September 11, 2025

Quantification of prostate cancer Gleason pattern 4 to predict oncological outcome.

Quantification of prostate cancer Gleason pattern 4 to predict oncological outcome.

Journal: BJU international

Published: August 07, 2025

ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients.

ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients.

Journal: European urology

Published: July 14, 2025

Focal Laser ablation in prostate diseases: Consolidating evidence and navigating future directions.

Focal Laser ablation in prostate diseases: Consolidating evidence and navigating future directions.

Journal: Diagnostic and interventional imaging

Published: May 14, 2025

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.

Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.

Journal: JAMA network open

Published: May 07, 2025

Arterial Embolization versus Robotic Partial Nephrectomy for the Treatment of Renal Angiomyolipomas.

Arterial Embolization versus Robotic Partial Nephrectomy for the Treatment of Renal Angiomyolipomas.

Journal: International braz j urol : official journal of the Brazilian Society of Urology

Published: March 28, 2025

Showing 1-12 of 309

Last Updated: 09/26/2026